manufacturing site |
means premises:
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
manufacturing site authorisation |
means an authorisation referred to in subsection 38(2B) or 40B(4).
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 38 Grant of licence
Therapeutic Goods Act 1989 - 3 Interpretation
|
medical device |
has the meaning given by section 41BD.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 41BD What is a medical device
Therapeutic Goods Act 1989 - 3 Interpretation
|
medical device classification |
means a classification specified in the regulations made for the purposes of section 41DB.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 41DB Medical device classifications
Therapeutic Goods Act 1989 - 3 Interpretation
|
medical device standard |
, in relation to a kind of medical device, means a medical device standard, specified in an order under section 41CB, that is applicable to that kind of medical device.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
medicine |
means therapeutic goods (other than biologicals) that are represented to achieve, or are likely to achieve, their principal intended action by pharmacological, chemical, immunological or metabolic means in or on the body of a human.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
member of EFTA |
means a country declared by the Minister under section 3A to be a member of the European Free Trade Association.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3A Declarationâmember of European Community
Therapeutic Goods Act 1989 - 3 Interpretation
|
member of the European Community |
means a country declared by the Minister under section 3A to be a member of the European Community.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3A Declarationâmember of European Community
Therapeutic Goods Act 1989 - 3 Interpretation
|
mother substance |
means any of the following:
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
Mutual Recognition Convention |
means the Convention for the Mutual Recognition of Inspections in respect of the Manufacture of Pharmaceutical Products done at Geneva on 8 October 1970.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
national emergency declaration |
has the same meaning as in the National Emergency Declaration Act 2020.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
non‐EC/EFTA attestation of conformity |
, for a non ‐ EC/EFTA MRA, means an attestation of conformity issued, after the non ‐ EC/EFTA MRA has come into force, by a conformity assessment body that is designated in the non ‐ EC/EFTA MRA and approved by the Secretary in writing for the non ‐ EC/EFTA MRA.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
non‐EC/EFTA MRA |
means an international instrument that Australia is bound by, or is a party to, if:
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
oath |
includes affirmation.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
occupier |
, in relation to premises, includes a person present at the premises who is in apparent control of the premises.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 45A Definitions
|
overseas regulator |
has the meaning given by section 41BIB.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 41BIB Overseas regulators
Therapeutic Goods Act 1989 - 3 Interpretation
|
overseas regulator conformity assessment document |
means a certificate or other document that is issued by an overseas regulator after that regulator is satisfied that requirements, comparable to the conformity assessment procedures, have been applied to a medical device by the manufacturer of the device.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
passed preliminary assessment |
:
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 41FDB Preliminary assessment of applications
Therapeutic Goods Act 1989 - 32DDA Preliminary assessment of applications
Therapeutic Goods Act 1989 - 3 Interpretation
Therapeutic Goods Act 1989 - 23 Applications generally
Therapeutic Goods Act 1989 - 23B Requirements relating to applications for registration of therapeutic goods and listing of medicines under section 26AE
|
period |
of a shortage of a medicine in Australia has the meaning given by section 30EIA.
|
Therapeutic Goods Act 1989 |
|
poison |
means an ingredient, compound, material or preparation which, or the use of which, may cause death, illness or injury and includes any ingredient, compound, material or preparation referred to in a schedule to the current Poisons Standard.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|